Ad hoc-Mitteilungen

Ad-hocs

Zeit Titel
14.09.20 Nestlé commences tender offer for Aimmune Therapeuti.
31.08.20 Nestlé to acquire Aimmune Therapeutics
30.07.20 Nestlé reports half-year results for 2020
11.06.20 Nestlé sharpens water focus on international, premium .
24.04.20 Nestlé reports three-month sales for 2020, provides CO.
23.04.20 Nestlé S.A. Annual General Meeting
24.03.20 Nestlé S.A. maintains date of Annual General Meeting, c.
24.03.20 Nestlé highlights innovation, digitalization and sustainab.
13.02.20 Nestlé proposes Hanne Jimenez de Mora as a new inde.
13.02.20 Nestlé reports full-year results for 2019
29.01.20 Novartis delivered strong sales growth, margin expansio.
29.01.20 Novartis erzielt 2019 ein starkes Umsatzwachstum, Mar.
27.01.20 Nestlé acquires Zenpep, expanding its medical nutrition .
06.01.20 Novartis completes tender offer for all outstanding share.
30.12.19 Nestlé completes CHF 20 billion share buyback progra.
19.12.19 Nestlé to sell 60% stake of Herta and create a joint vent.
16.12.19 Novartis provides update on LUSTER Phase III studies i.
11.12.19 Nestlé makes strategic move to create global leader in i.
05.12.19 Novartis tender offer for The Medicines Company comm.
24.11.19 Novartis to acquire The Medicines Company for USD 9.
15.11.19 New Novartis medicine Adakveo® (crizanlizumab) appro.
01.11.19 Novartis Cosentyx® shows encouraging results versus .
30.10.19 Novartis announces AVXS-101 intrathecal study update
22.10.19 Novartis delivered another strong quarter with double dig.
22.10.19 Novartis verzeichnet ein weiteres starkes Quartal mit zw.
17.10.19 Nestlé announces changes to its waters business, esta.
17.10.19 Nestlé reports nine-month sales for 2019
02.10.19 Novartis positive 52-week PREVENT data confirm Cose.
17.09.19 Novartis Cosentyx® positive 16-week PREVENT results .
30.08.19 Novartis ofatumumab demonstrates superiority versus A.
05.11.18 Novartis R&D update highlights industry leading develop.
10.10.18 Novartis announces new data from the first direct head-t.
20.09.18 Nestlé to sharpen its Nutrition, Health and Wellness stra.
17.09.18 Nestlé agrees to sell Gerber Life Insurance Co. to Weste.
11.09.18 Alcon bestätigt vor dem vorgeschlagenen Spin-off von N.
11.09.18 Alcon confirms commitment to Switzerland ahead of pro.
29.08.18 Alcon announces voluntary global market withdrawal of .
28.08.18 Nestlé and Starbucks close deal for the perpetual global.
27.08.18 Novartis erhält die Zulassung für seine CAR-T-Zell-Ther.
27.08.18 Novartis receives European Commission approval of its .
25.08.18 Novartis announces new data that show Entresto® (sac.
26.07.18 Nestlé reports half-year results for 2018
23.07.18 Novartis renews drug donation of Egaten® (triclabendaz.
19.07.18 Novartis demonstrates commitment to lead immuno-der.
02.07.18 Nestlé Outlines Value Creation Progress
16.05.18 Novartis kündigt Veränderungen in der Geschäftsleitung .
16.05.18 Novartis announces changes to the Executive Committee
18.04.18 Sandoz signs agreement with Pear Therapeutics to deve.
16.04.18 Novartis announces new analysis demonstrating Entres.
27.03.18 Novartis verkauft Beteiligung an Consumer-Healthcare-J.
    Nächste Nächste    

Newssuche


Schließen